Efficacy and safety of co-administered cagrilintide-semaglutide…
Two lower doses of a once-weekly injection helped people lose roughly 20% of their body weight over 68 weeks, suggesting more flexible treatment options for weight management.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Efficacy of homoharringtonine (HHT)-based induction regimen in acute…
A chemotherapy regimen achieves unusually high remission rates in a subset of acute leukemia with specific genetic mutations, offering hope for this favorable-risk group.
Promising but preliminaryOmega-3 Fatty Acid Supplementation Has Coronary and Other Selective…
Omega-3 supplements reduce heart attacks and fatal heart disease in some populations, particularly people who eat little fish, though they don't prevent cancer or all types of cardiovascular disease.
Promising but preliminaryReal-world access and barriers to CAR T-cell therapy in…
Two-thirds of patients with relapsed lymphoma accessed CAR-T cell therapy in a public Canadian program with strong survival rates, showing that access barriers are medical fit rather than geographic.
Promising but preliminaryClinical outcomes of GLP-1 receptor agonists VS placebo among…
GLP-1 receptor agonists reduce hospitalization from heart failure in patients with obesity or diabetes, addressing a major gap in treatment options for this condition.